{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_dopamine_agonists",
          "name": "Dopamine Agonists"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_selective_serotonin_reuptake_inhibitors",
          "name": "Selective Serotonin Reuptake Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_norepinephrine_reuptake_inhibitors",
          "name": "Norepinephrine Reuptake Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_anxiolytics",
          "name": "Anxiolytics"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_antidepressants",
          "name": "Antidepressants"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_mood_stabilizers",
          "name": "Mood Stabilizers"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_atypical_antipsychotics",
          "name": "Atypical Antipsychotics"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_mao_inhibitors",
          "name": "MAO Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cognitive_enhancers",
          "name": "Cognitive Enhancers"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_cholinesterase_inhibitors",
          "name": "Cholinesterase Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_glutamate_modulators",
          "name": "Glutamate Modulators"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_serotonin_norepinephrine_reuptake_inhibitors",
          "name": "Serotonin-Norepinephrine Reuptake Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 4
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_dopamine_agonists",
          "type": "Drug",
          "label": "Dopamine Agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_selective_serotonin_reuptake_inhibitors",
          "type": "Drug",
          "label": "Selective Serotonin Reuptake Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_norepinephrine_reuptake_inhibitors",
          "type": "Drug",
          "label": "Norepinephrine Reuptake Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anxiolytics",
          "type": "Drug",
          "label": "Anxiolytics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antidepressants",
          "type": "Drug",
          "label": "Antidepressants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mood_stabilizers",
          "type": "Drug",
          "label": "Mood Stabilizers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atypical_antipsychotics",
          "type": "Drug",
          "label": "Atypical Antipsychotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mao_inhibitors",
          "type": "Drug",
          "label": "MAO Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cognitive_enhancers",
          "type": "Drug",
          "label": "Cognitive Enhancers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cholinesterase_inhibitors",
          "type": "Drug",
          "label": "Cholinesterase Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_glutamate_modulators",
          "type": "Drug",
          "label": "Glutamate Modulators",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_serotonin_norepinephrine_reuptake_inhibitors",
          "type": "Drug",
          "label": "Serotonin-Norepinephrine Reuptake Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_dopamine_receptors",
          "type": "Target",
          "label": "Dopamine Receptors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_serotonin_receptors",
          "type": "Target",
          "label": "Serotonin Receptors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_norepinephrine_receptors",
          "type": "Target",
          "label": "Norepinephrine Receptors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_neurotransmitter_signaling",
          "type": "Pathway",
          "label": "Neurotransmitter Signaling Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_neurotransmitter_disorders",
          "type": "Disease",
          "label": "Neurotransmitter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_dopamine_agonists",
          "target": "target_dopamine_receptors",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "广泛用于多种神经传递失调的常识"
        },
        {
          "source": "drug_selective_serotonin_reuptake_inhibitors",
          "target": "target_serotonin_receptors",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "被广泛用于抑郁症的治疗，相关性强"
        },
        {
          "source": "drug_norepinephrine_reuptake_inhibitors",
          "target": "target_norepinephrine_receptors",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于抑郁症及焦虑的治疗，展现其有效性"
        },
        {
          "source": "target_dopamine_receptors",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "神经传递信号通路中的关键部分"
        },
        {
          "source": "target_serotonin_receptors",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "参与神经传递过程"
        },
        {
          "source": "target_norepinephrine_receptors",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "在神经传递中起重要作用"
        },
        {
          "source": "pathway_neurotransmitter_signaling",
          "target": "disease_neurotransmitter_disorders",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "损伤或失调影响神经传递产生相关疾病"
        },
        {
          "source": "drug_anxiolytics",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过影响神经递质起作用"
        },
        {
          "source": "drug_antidepressants",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有效调节神经传递失调"
        },
        {
          "source": "drug_mood_stabilizers",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响多种神经递质，常用于情绪稳定"
        },
        {
          "source": "drug_atypical_antipsychotics",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "针对神经传递紊乱的治疗选项"
        },
        {
          "source": "drug_mao_inhibitors",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "通过抑制单胺氧化酶改善症状"
        },
        {
          "source": "drug_cognitive_enhancers",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "改善认知功能，相关于神经传递"
        },
        {
          "source": "drug_cholinesterase_inhibitors",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "影响神经传递，通常用于阿尔茨海默病"
        },
        {
          "source": "drug_glutamate_modulators",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "在学习和记忆中的作用"
        },
        {
          "source": "drug_serotonin_norepinephrine_reuptake_inhibitors",
          "target": "pathway_neurotransmitter_signaling",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "同时影响5-羟色胺和去甲肾上腺素"
        },
        {
          "source": "drug_dopamine_agonists",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过激动多巴胺受体改善症状"
        },
        {
          "source": "drug_selective_serotonin_reuptake_inhibitors",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "选择性抑制5-羟色胺再摄取对于诸多疾病有效"
        },
        {
          "source": "drug_norepinephrine_reuptake_inhibitors",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有效调节去甲肾上腺素水平"
        },
        {
          "source": "drug_anxiolytics",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于焦虑症的治疗"
        },
        {
          "source": "drug_antidepressants",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "针对于抑郁症的治疗选项"
        },
        {
          "source": "drug_mood_stabilizers",
          "target": "H6",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过稳定情绪达到治疗效果"
        },
        {
          "source": "drug_atypical_antipsychotics",
          "target": "H7",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "针对精神病患者的治疗"
        },
        {
          "source": "drug_mao_inhibitors",
          "target": "H8",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响单胺水平，改善症状"
        },
        {
          "source": "drug_cognitive_enhancers",
          "target": "H9",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "通过增强认知功能补救"
        },
        {
          "source": "drug_cholinesterase_inhibitors",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于神经退行性疾病"
        },
        {
          "source": "drug_glutamate_modulators",
          "target": "H11",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "参与学习记忆的改善"
        },
        {
          "source": "drug_serotonin_norepinephrine_reuptake_inhibitors",
          "target": "H12",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "同时调节血清素和去甲肾上腺素"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过不同机制对神经递质失调产生影响",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "药物影响多种神经递质相关的信号通路",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物具有到达相关靶组织的最小暴露（常识判断）"
    ],
    "uncertainties": [
      "药物的长期影响尚需进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需探索其他药物类别以支持不同类型的神经递质失调"
    ]
  }
}